Table 1.
Relationships between AHR expression and clinicopathological parameters of lung cancer
| n | AHR expression | |||
|---|---|---|---|---|
| Positive (%) | Negative (%) | p value | ||
| Total | 30 | 18 (60) | 12 (40) | |
| Age | ||||
| >60 | 13 | 9 (70) | 4 (30) | 0.366 |
| ≤60 | 17 | 9 (53) | 8 (47) | |
| Gender | ||||
| Male | 26 | 16 (62) | 10 (38) | 0.661 |
| Female | 4 | 2 (50) | 2 (50) | |
| Cell type | ||||
| Adenocarcinoma | 7 | 4 (57) | 3 (43) | 0.064 |
| Squamous cell carcinoma | 12 | 9 (75) | 3 (25) | |
| Adenosquamous carcinoma | 3 | 3 (100) | 0 (0) | |
| Metastatic adenocarcinoma | 8 | 2 (25) | 6 (75) | |
| Grade | 0.878 | |||
| 1 | 6 | 4 (67) | 2 (33) | |
| 2 | 11 | 6 (55) | 5 (45) | |
| 3 | 13 | 8 (62) | 5 (38) | |
| TNM | ||||
| T1 | 1 | 0 (0) | 1 (100) | 0.09 |
| T2 | 19 | 14 (74) | 5 (26) | |
| T3 | 10 | 4 (40) | 6 (60) | |
| N0 | 9 | 5 (56) | 4 (44) | 0.88 |
| N1 | 9 | 6 (67) | 3 (33) | |
| N2 | 12 | 7 (58) | 5 (42) | |
| M0 | 22 | 16 (73) | 6 (27) | 0.018 |
| M1 | 8 | 2 (25) | 6 (75) | |